Inflatable penile prosthesis implantation in the outpatient setting is safe and feasible: a prospective, singe center study

Inflatable penile prosthesis (IPP) implantations are commonly performed in hospital settings which accommodate an overnight stay and are increasingly being performed as day procedures in outpatient settings with same-day discharge. This study sought to investigate the safety and feasibility of day surgery insertion of an IPP. Surgical parameters and incidence of postoperative complications including infection, hospital admission, emergency room visitation, and additional analgesia were investigated. This prospective study included all adult patients undergoing day surgery insertion of an IPP at an ambulatory surgical center classified as ASA 1-3, between February 2023 and April 2024. All procedures were performed via infrapubic approach under spinal anesthesia or deep sedation with local anesthesia. 52 patients were enrolled with a mean age of 62.5 ± 3.1 [43-79] years. All procedures were performed successfully with no intra-operative complications. The mean surgery duration was 65.2 ± 17.9 [35-130] minutes. The mean recovery time was 115.9 ± 58.2 [50-323] minutes. No patients required hospital admission or had acquired a post-operative infection. One patient required emergency room visitation, which was unrelated to the surgery. 5.9% (n = 3) of patients required additional postoperative analgesia. Our results demonstrate the safety and feasibility of performing an IPP implantation in an outpatient setting.